Divalproex Sodium Extended-Release tablets 125mg Divalproex Sodium Extended-Release tablets 250mg Divalproex Sodium Extended-Release tablets 500mg PACKAGE LEAFLET: INFORMATION FOR THE USER Divalproex Sodium ER tablets 125mg, 250mg and 500mg Tablets valproic acid (as valproate semisodium) This medicine is subject to additional monitoring. This will allow quick identification of new safety...
Divalproex Sodium Extended-Release tablets 125mg Divalproex Sodium Extended-Release tablets 250mg Divalproex Sodium Extended-Release tablets 500mg PACKAGE LEAFLET: INFORMATION FOR THE USER Divalproex Sodium ER tablets 125mg, 250mg and 500mg Tablets valproic acid (as valproate semisodium) This medicine is subject to additional monitoring. This will allow quick identification of new safety...
Tinidazole Tablets 500mgTinidazole Tablets 1000mg Package leaflet: Information for the user Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. ? Keep this leaflet. You may need to read it again. ? If you have any further questions, ask your...
Tinidazole Tablets 500mgTinidazole Tablets 1000mg Package leaflet: Information for the user Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. ? Keep this leaflet. You may need to read it again. ? If you have any further questions, ask your...
Choline Fenofibrate Delayed-Release Tablets 45mgCholine Fenofibrate Delayed-Release Tablets 135mg DESCRIPTION Choline Fenofibrate Delayed-Release Tablets (fenofibric acid) is a lipid regulating agent available as a delayed-release tablet for oral administration. Each delayed-release tablet contains choline fenofibrate, equivalent to 45 mg or 135 mg of fenofibric acid. The chemical name for choline...
Choline Fenofibrate Delayed-Release Tablets 45mgCholine Fenofibrate Delayed-Release Tablets 135mg DESCRIPTION Choline Fenofibrate Delayed-Release Tablets (fenofibric acid) is a lipid regulating agent available as a delayed-release tablet for oral administration. Each delayed-release tablet contains choline fenofibrate, equivalent to 45 mg or 135 mg of fenofibric acid. The chemical name for choline...
Seratrodast Tablets 40mgSeratrodast Tablets 80mg DESCRIPTION Seratrodast is an orally active quinone derivative and a potent TXA2 receptor antagonist used in the prophylactic management of asthma and treatment of allergic rhinitis. Structure of Seratrodast Chemical name:???-7-?3?5?6-trimethyl-1?4-benzoquinone-2-yl?-7-phenylheptanoic acid (?) 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid Molecular formula: C22 H26 O4 Molecular weight: 354.44 COMPOSITION a) Seratrodast Tablets 40mg Taj Pharma Each tablet...
Seratrodast Tablets 40mgSeratrodast Tablets 80mg DESCRIPTION Seratrodast is an orally active quinone derivative and a potent TXA2?receptor antagonist used in the prophylactic management of asthma and treatment of allergic rhinitis. Structure of Seratrodast Chemical name:???-7-?3?5?6-trimethyl-1?4-benzoquinone-2-yl?-7-phenylheptanoic acid?(?) 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid Molecular formula: C22 H26 O4 Molecular weight:?354.44 COMPOSITION a) Seratrodast Tablets 40mg Taj Pharma Each tablet...
Cinacalcet Hydrochloride Tablets 30mgCinacalcet Hydrochloride Tablets 60mgCinacalcet Hydrochloride Tablets 90mg DESCRIPTION Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH). This hormone...
Cinacalcet Hydrochloride Tablets 30mgCinacalcet Hydrochloride Tablets 60mgCinacalcet Hydrochloride Tablets 90mg DESCRIPTION Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH). This hormone...